Rationalization of Drug Therapy of ENT (Ear Nose Throat) Diseases

Background: Drug therapy in ENT very often requires the combined prescription of a number of products depending on the symptoms found. Some rationalization of this therapy is necessary to better adapt it to the causal condition. Objectives: To assess the habits of ENT drug prescription and propose the principles of a rationalization of the treatment of common ENT conditions. Study Framework: District Hospital IV of Bamako, Mali. Patients and Methods: Patients: The retrospective study identified the drug prescription habits of common ENT conditions by practitioners in the department involving 110 patients during the year 2020. Methods: All patients in the study received medication management. Results: The mean age of patients was 26 years with extremes from 01 months to 76 years. A predominance of the female sex was noted: 59 cases (54%). An optimal standard treatment was proposed taking into account the symptomatology of the study's common ENT conditions (acute pharyngitis, acute otitis media, rhinitis, rhinosinusitis). Three-product prescription predominated in 45 Patients (48.39%). The most used products were: antibiotics [91 times (27.33%)], nonsteroidal anti-inflammatory drugs [86 times (25.82%)], analgesics [36 times (10.80%)]. Our drug prescribing habits have been close to those defined in the proposed standard optimum treatment. Conclusion: this study confirms that the therapeutic attitudes of our unit are rational because they are close to the standard optimal treatments proposed. Our work represents a tool of adequate approaches for health personnel who must opt for a rationalization of the treatment of common ENT conditions considering their clinical particularities in tropical environments.